Vmbook Online ordering

Icons

I'm glad to help you with that!

The company you're referring to is called Brickell Biotech, Inc. (Ticker: BBi), which is a clinical-stage biotechnology company focused on the development of innovative treatments for skin diseases.

As of their most recent quarterly report (Q3 2021), Brickell Biotech reported a net loss of $6.1 million, or $0.16 per share, compared to a net loss of $5.2 million, or $0.19 per share, for the same period in 2020. This represents a year-over-year increase in net loss of approximately 17%.

The company's revenue for the first nine months of 2021 was $0.3 million, compared to $0.1 million for the same period in 2020. This represents an increase in revenue of approximately 150%.

Brickell Biotech's lead product candidate is sofpironium bromide, a topical gel for the potential treatment of primary axillary hyperhidrosis (excessive underarm sweating). The company is currently conducting a Phase 3 clinical trial for this product candidate.

It's important to note that investing in the stock market always carries risk, and it's important to conduct your own research and consider seeking advice from a financial advisor before making any investment decisions.

I hope this information is helpful! Let me know if you have any other questions.